Overexpression of Gm10451 suppressed G6PD, aggravated oxidative/ER stress and inflammation, inhibited insulin secretion and promoted β-cell apoptosis, representing a poteniall therapeutic target for diabetes-related β-cell dysfunction.
Abstract
Pancreatic β-cell dysfunction underlies type 1 diabetes mellitus (T1DM) progression. Previous study showed that lncRNA Gm10451 is upregulated by high glucose and contributes to β-cell impairment, but its mechanism remains unclear. Interactions among Gm10451, miR-24-3p, and G6PD were validated by dual-luciferase assay and Ago2-RNA immunoprecipitation (Ago2-RIP). Expression was measured by RT-qPCR and Western blot. β-cell functions were evaluated by glucose-stimulated insulin secretion (GSIS), CCK-8, TUNEL, ELISA, and hyperglycemic clamp in 30 mM glucose-treated MIN6 cell and STZ-treated C57BL/6 mice (Control injected with citrate buffer). Gm10451 was upregulated in diabetic models. Gm10451 acted as ceRNA to spomge miR-24-3p, which directly targeted G6PD. Overexpression of Gm10451 suppressed G6PD, aggravated oxidative/ER stress and inflammation, inhibited insulin secretion and promoted β-cell apoptosis. miR-24-3p mimic reversed these impairments. Gm10451 promotes β-cell dysfunction via the miR-24-3p/G6PD axis, representing a poteniall therapeutic target for diabetes-related β-cell dysfunction.
Findings reveal that the LINC01419–miR-132-3p–USP38 axis mediates ferroptosis in vascular endothelial cells under hyperglycemia, and suggest USP38 as a potential therapeutic target for T2DM.
Ke-Ke Tang, Wen-Ji Gao, Xin-Xing Wo et al.· Scientific Reports· 0 citations
Pancreatic β-cell dedifferentiation is a pathological mechanism that contributes to β-cell dysfunction and loss during type 2 diabetes (T2D), but the underlying mechanisms remain incompletely understood. MicroRNAs (miRNAs) are key post-transcriptional regulators of cellular identity and function. We previously identifi...
The core pathological feature of type 2 diabetes mellitus (T2DM) is pancreatic β-cell failure; therefore, the identification of effective circulating biomarkers and molecular targets that regulate pancreatic β-cell homeostasis is of significant practical importance. As key regulatory molecules of gene expression, miRNA...
NR2F1-AS1 serves as a potential non-invasive biomarker and promising therapeutic target for DPN by driving Schwann cell dysfunction via the NR2F1-AS1/miR-150-5p/TP53 axis.
Ya-Zhi Zhao, Shi-Ling Rong, Xiao-Ya Ren et al.· Molecular and Cellular Probe...· 0 citations
Findings establish a causal axis in which lncRNA TUG1 derepresses caspase-3 and suppresses Akt/GSK-3β signaling by sponging miR-449a-5p, thereby driving neuronal lipotoxic injury.
Yang-Wa Wei, Peng-Yao Chen, Xin Zheng et al.· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.